| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424157100 | Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.) | 31 |
| 20080254038 | Immunogen adherence inhibitor directed to lactobacillus organisms and method of making and using it - A microbial adherence inhibitor specific to lactic acid producing microorganisms, in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment or adherence of colony-forming immunogens in the fermentators. The inhibitor is made by inoculating female birds with the immunogen, allowing time for an immune response in the female bird and then harvesting the eggs that contain antibodies to the immunogen. The egg contents can be dried or used as a liquid and added to the media in the fermentators. Dependent upon the particular immunogen with which the female bird is inoculated, the egg antibody will specifically bind to the specific immunogen. When bacteria such as | 10-16-2008 |
| 20090092621 | ANTIBODIES FOR PREVENTING AND TREATING ATTACHING AND EFFACING ESCHERICHIA COLI (AEEC) ASSOCIATED DISEASES - The present invention relates to antibodies immunologically specific for an attaching and effacing | 04-09-2009 |
| 20090117129 | Immunogen adherence inhibitor directed to lactobacillus organisms and method of making and using it - A microbial adherence inhibitor specific to lactic acid producing microorganisms, in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment or adherence of colony-forming immunogens in the fermentators. The inhibitor is made by inoculating female birds with the immunogen, allowing time for an immune response in the female bird and then harvesting the eggs that contain antibodies to the immunogen. The egg contents can be dried or used as a liquid and added to the media in the fermentators. Dependent upon the particular immunogen with which the female bird is inoculated, the egg antibody will specifically bind to the specific immunogen. When bacteria such as | 05-07-2009 |
| 20090214567 | Immunoglobulin Fraction and Process Therefor - The invention relates to the production of compositions containing IgA for use as a food additive. More specifically, it relates to a process to prepare an IgA-enriched milk product extract composition and to such compositions. | 08-27-2009 |
| 20090246207 | Calf Biologic Anti-Scour Supplement (CBAS) - A composition for prevention digestive infection in a ruminant infant is disclosed. The composition consists of: a predetermined amount of yolk immunoglobulin (IgY) for a target bacteria; a predetermined amount of a plurality of hormones and a predetermined amount of a plurality of proteins, wherein said plurality of hormones comprises of a group consisting of bovine insulin (bIns), bovine growth hormone (bGH), and bovine prolactine (bPrl), and wherein said plurality of proteins comprises of a group consisting of, bovine insulin like growth factor (bIGF), lactoferrin factor (LF), and transferring factor (TF); and a predetermined amount of bacterial biomass, wherein said bacterial biomass comprises of a group consisting of bacterial DNA, bacterial RNA, bacterial protein, and bacterial polysaccharides. | 10-01-2009 |
| 20090297534 | Catalytic Immunoglobulins BBK32 and Uses Therefor - The present invention describes the composition of class and subclass selected pooled human immunoglobulins with catalytic activity, methods of preparation thereof, and therapeutic utility thereof. | 12-03-2009 |
| 20100068213 | SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS - The invention relates to the treatment of intestinal barrier function disorders involving administration of a selected colostrum comprising more than 25 weight % undenatured immunoglobulin G(IgG) based on the weight of total protein content of said colostrum to a subject. The invention further relates to compositions comprising colostrum and indigestible dietary fibers wherein the colostrum comprises more than 25 weight % undenatured immunoglobulin G based on the weight of total protein content of said colostrum. | 03-18-2010 |
| 20100129377 | MILK DERIVED ANTIGEN-SPECIFIC ANTIBODIES, METHODS OF PREPARATION AND USES THEREOF - The invention relates to means and methods for obtaining an antigen specific antibody from milk from non-human mammals that have not been immunized with said antigen prior to collecting said milk. Non-human mammal derived antigen specific antibody was found to cross the mucosal side of the intestinal tract of an individual. The invention provides novel means and methods for the treatment of disease through antigen specific non-human mammal antibodies. Further provided are preparations for oral administration comprising said antigen specific antibody of a ruminant. | 05-27-2010 |
| 20100266607 | ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT - In accordance with the invention, the development and use of antibodies within the digestive tract is provided. Antibodies are described that are used to treat disorders associated with altered permeability of the digestive tract. Antibodies are described with increased stability within the environment of the digestive tract. Antibodies are described with enhanced permeability to a compromised digestive tract. | 10-21-2010 |
| 20100297140 | USES OF ANTIBODIES - The present invention provides a method of preparing an antibody-containing milk or egg product for use in preventing and/or treating of a non-infectious medical condition. The invention also provides non-systemic modes of administering pharmaceutical compositions including the antibody-containing milk or egg products, including to the GI tract. | 11-25-2010 |
| 20100297141 | ANTI-ADHESIN BASED PASSIVE IMMUNOPROPHLACTIC - The invention relates to an immunogenic composition and method of the immunogenic composition for the production and administration of a passive immunoprophylactic against enterotoxigenic | 11-25-2010 |
| 20110008361 | Treatment Method - A treatment composition for treating or preventing bovine mastitis, the treatment composition characterised in that it includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk, or a milk derived substance. | 01-13-2011 |
| 20110008362 | ANTI-GLUTEN EGG YOLK ANTIBODIES FOR THE TREATMENT OF CELIAC DISEASE - The present invention relates to compositions for ameliorating the symptoms of celiac disease or gluten sensitive enteropathy comprising egg yolk antibodies against gluten, including gliadin, high molecular glutenin, low molecular glutenin and mixtures of the three peptides. The antibodies may be produced by immunizing laying hens with immunogenic preparations of gluten and harvesting the eggs and egg yolks. | 01-13-2011 |
| 20110159002 | STABILIZED LIQUID EGG MATERIAL FOR EXTENDED SHELF LIFE - The present invention is directed to shelf-stable liquid egg material, methods for making the same, and method of using the same. The present invention is also directed to an animal feed supplement containing a stabilized IgY antibody titer in liquid eggs stored at room temperature for extended periods of time with the use of glycerol and preservatives. The stabilized liquid whole egg or stabilized liquid yolks of the egg containing non-specific or elevated specific IgY titer may be used as animal feed supplements animals to provide passive immunity to these animals. The stabilized nature of the IgY and liquid egg allows for extended shelf life of these liquid products at room temperature. | 06-30-2011 |
| 20110206684 | METHOD OF PRODUCING NUTRITIONAL PRODUCTS FROM HUMAN MILK TISSUE AND COMPOSITIONS THEREOF - Methods of isolating, treating, storing and processing human milk, as well as nutritional formulations of human milk comprising protective human milk proteins. | 08-25-2011 |
| 20110268743 | PROBIOTICS, SECRETORY IgA AND INFLAMMATION - The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with SIgA and possible uses of this combination. For example a use of a composition comprising SIgA and at least one probiotic for the preparation of a product to treat or prevent inflammation is disclosed. | 11-03-2011 |
| 20110274701 | COMPOSITION AND METHOD FOR PREVENTING/DECREASING RESPIRATORY ILLNESS - A microbial adherence inhibitor in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment of adherence of colony-forming immunogens in the respiratory tracts of host animals and humans. The inhibitor is made by inoculating female birds with the immunogen, harvesting the eggs which contain antibodies to the immunogen, and separating the yolk and albumin from the shells of the eggs. The yolk and albumin contents are administered to animals or human by distributing the contents directly or introducing the contents entrained in air. The adherence inhibiting material can be formulated for use in a variety of ways such as an oral spray or a nasal spray. These formulations can be effective to prevent or reduce respiratory illnesses in animals and humans. | 11-10-2011 |
| 20120009198 | Compositions and Methods for Modulating Immune Response - The present invention relates to a method for modulating immune response in a subject, which comprises administering to the subject an effective amount of a composition comprising a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using | 01-12-2012 |
| 20120014963 | PROBIOTICS, SECRETORY IGA AND INFECTION - The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example a use of a composition comprising secretory IgA and at least one probiotic for the preparation of a product to treat or prevent infection is disclosed. | 01-19-2012 |
| 20120020982 | FORMULATIONS AND TREATMENTS FOR TRICHOLOGY - A formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of | 01-26-2012 |
| 20130011410 | Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule - The present invention provides the method for prevention and treatment of specific localized intestinal infections and diseases using IgA and IgM antibodies obtained from the eggs of hens which have been hyperimmunized to the same specific infections and diseases. The invention describes the high functionality of IgA and IgM antibodies present in the white of an egg from a hyperimmunized chicken as compared to the IgY from the same egg. The invention also describes the resistance of IgA and IgM to low pH environments such as stomach acids. The invention also describes the inhibition of bacterial growth when bacteria are exposed to IgA antibodies specific to said bacteria together with lysozyme from egg whites. | 01-10-2013 |
| 20130045213 | ANTIBODY THERAPY FOR MODULATING FUNCTION OF INTESTINAL RECEPTORS AND METHODS OF TREATING DIABETES AND OBESITY - The present invention provides pharmaceutical compositions formulated for direct delivery to the GI tract of a patient comprising an antibody specific for a target apical intestinal receptor. The present invention further provides methods of treating diseases and conditions in a patient comprising administering directly to the GI tract of the patient, compositions of the present invention wherein modulation of the target apical intestinal receptor by the antibody treats the condition. | 02-21-2013 |
| 20130164302 | Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders - The present invention relates to immunomodulatory compositions comprising mammalian colostrum-derived immunoglobulin preparation and optionally further colostrums, milk or milk product component/s and any adjuvants for treating immune-related disorders. More specifically, the invention provides compositions comprising colostrum-derived anti-insulin immunoglobulin preparations for the treatment of Metabolic Syndrome. The invention further provides methods and uses of the immunomodulatory compositions for an active or passive immunization in a disease-antigen specific or non specific manner. | 06-27-2013 |
| 20130224216 | ANTI-LPS ENRICHED IMMUNOGLOBULIN FOR USE IN TREATMENT AND/OR PROPHYLAXIS OF A PATHOLOGIC DISORDER - Methods and compositions for treating conditions including liver dysfunction, e.g., associated with fatty liver; glucose intolerance; and others, by administering compositions comprising anti-LPS immunoglobulin enriched colostrum preparations. | 08-29-2013 |
| 20130330354 | STABILIZED LIQUID EGG MATERIAL FOR EXTENDED SHELF LIFE - The present invention is directed to shelf-stable liquid egg material, methods for making the same, and method of using the same. The present invention is also directed to an animal feed supplement containing a stabilized IgY antibody titer in liquid eggs stored at room temperature for extended periods of time with the use of glycerol and preservatives. The stabilized liquid whole egg or stabilized liquid yolks of the egg containing non-specific or elevated specific IgY titer may be used as animal feed supplements animals to provide passive immunity to these animals. The stabilized nature of the IgY and liquid egg allows for extended shelf life of these liquid products at room temperature. | 12-12-2013 |
| 20140065161 | TREATMENT METHOD FOR MICROBIAL INFECTION - A treatment composition for treating or preventing bovine mastitis, the treatment composition characterised in that it includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk, or a milk derived substance. | 03-06-2014 |
| 20140147446 | ANTIBODY THERAPY FOR MODULATING FUNCTION OF INTESTINAL RECEPTORS AND METHODS OF TREATING DIABETES AND OBESITY - The present invention provides pharmaceutical compositions formulated for direct delivery to the GI tract of a patient comprising an antibody specific for a target apical intestinal receptor. The present invention further provides methods of treating diseases and conditions in a patient comprising administering directly to the GI tract of the patient, compositions of the present invention wherein modulation of the target apical intestinal receptor by the antibody treats the condition. | 05-29-2014 |
| 20150344545 | Method of Treating and Preventing Infectious Diseases Using Colostrum - A method of treating and/or preventing infectious disease in mammals, such as canines, includes administering an effective amount of a colostral composition to a mammal which has been produced by a donor mammal and includes at least one type of antibody having a binding specificity for at least one pathogen. The at least one type of antibody is generated by the donor mammal in response to being challenged with at least one challenge material. | 12-03-2015 |
| 20160083457 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE - The present invention relates to methods and compositions for the treatment and/or prophylaxis of | 03-24-2016 |
| 20160106834 | PROBIOTICS, SECRETORY IgA AND INFECTION - Ways to increase the effectiveness of probiotics is disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition comprising secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed. | 04-21-2016 |
| 20160251414 | ANTI-LPS ENRICHED IMMUNOGLOBULIN FOR USE IN TREATMENT AND/OR PROPHYLAXIS OF FIBROSIS | 09-01-2016 |
